Parkinson Disease Clinical Trials in Houston, Texas

5 studies are recruiting for parkinson disease in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

    The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the activity of the "leucine-rich repeat kinase 2" ("LRRK2" for short) pathway based on their genetic p…

    Stage
    Phase 2
    Ages
    40 to 80
    Site
    Baylor College of Medicine, Houston, Texas
    Locations
    72 in total
    Run by
    Neuron23 Inc.
  2. PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

    The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest…

    Stage
    Not phased
    Ages
    30 and older
    Site
    Baylor College of Medicine, Houston, Texas
    Locations
    50 in total
    Run by
    Michael J. Fox Foundation for Parkinson's Research
  3. A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

    The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered to the putamen in subjects with moderate Parkinson's Disease.

    Stage
    Phase 2
    Ages
    45 to 75
    Site
    Houston Methodist (Neurology), Houston, Texas
    Locations
    46 in total
    Run by
    AskBio Inc
  4. Black and African Americans Connections to Parkinson's Disease (BLAAC PD)

    BLAAC PD is a research study to understand what Parkinson's disease looks like for Black and African American communities. BLAAC PD is happening at research centers around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to tra…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Texas Health Science Center, Houston, Houston, Texas
    Locations
    12 in total
    Run by
    Michael J. Fox Foundation for Parkinson's Research
  5. A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

    The primary purpose of this study is to evaluate efficacy and safety of CREXONT under real world conditions in participants with Parkinson disease (PD).

    Stage
    Phase 4
    Ages
    18 and older
    Site
    The University of Texas Health Science Center at Houston- McGovern Medical School, Houston, Texas
    Locations
    27 in total
    Run by
    Impax Laboratories, LLC

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.